Markey John 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-27 11:09 am Sale |
2022-12-14 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Markey John | 0 0.000% |
-28,316 (Position Closed) |
Filing |
| 2022-09-28 5:47 pm Purchase |
2022-09-28 | 13G | Vallon Pharmaceuticals, Inc. VLON |
Markey John | 28,316 8.100% |
28,316 (New Position) |
Filing |